Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Odyssey Therapeutics
Biotech
Lonza lands new CEO—Chutes & Ladders
Lonza nabs new CEO after acquiring Roche site. Amgen R&D leader jumps to Acadia. Three C-suite leaders depart I-Mab.
Gabrielle Masson
,
Max Bayer
Apr 5, 2024 8:30am
Odyssey raises epic $101M to push programs off to clinical sea
Dec 5, 2023 11:01am
Lilly picks new head of diabetes, obesity unit—Chutes & Ladders
Oct 6, 2023 9:30am
Glick's Odyssey raises $168M to gear up for clinic
Oct 13, 2022 6:30am
Aquestive CEO departs with seizure med in limbo—Chutes & Ladders
May 20, 2022 9:30am
Gary Glick's Odyssey begins with $218M for 7 assets
Dec 7, 2021 7:00am
